A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
CT900(一种新型α-叶酸受体介导的胸苷酸合成酶抑制剂)在实体瘤患者中的I期临床试验,并纳入高级别浆液性卵巢癌患者作为扩展队列。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-1268
Banerjee, Susana; Michalarea, Vasiliki; Ang, Joo Ern; Ingles Garces, Alvaro; Biondo, Andrea; Funingana, Ionut-Gabriel; Little, Martin; Ruddle, Ruth; Raynaud, Florence; Riisnaes, Ruth; Gurel, Bora; Chua, Sue; Tunariu, Nina; Porter, Joanna C; Prout, Toby; Parmar, Mona; Zachariou, Anna; Turner, Alison; Jenkins, Ben; McIntosh, Stuart; Ainscow, Ed; Minchom, Anna; Lopez, Juanita; de Bono, Johann; Jones, Robert; Hall, Emma; Cook, Natalie; Basu, Bristi; Banerji, Udai